TXG vs. BBP
Compare and contrast key facts about 10x Genomics, Inc. (TXG) and Virtus LifeSci Biotech Products ETF (BBP).
BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TXG or BBP.
Key characteristics
| TXG | BBP | |
|---|---|---|
| YTD Return | -74.77% | 9.19% |
| 1Y Return | -65.06% | 29.24% |
| 3Y Return (Ann) | -55.39% | 8.06% |
| 5Y Return (Ann) | -27.00% | 9.79% |
| Sharpe Ratio | -1.01 | 1.31 |
| Sortino Ratio | -1.67 | 1.88 |
| Omega Ratio | 0.79 | 1.22 |
| Calmar Ratio | -0.69 | 1.37 |
| Martin Ratio | -1.26 | 3.95 |
| Ulcer Index | 51.21% | 7.32% |
| Daily Std Dev | 63.93% | 22.09% |
| Max Drawdown | -93.02% | -44.32% |
| Current Drawdown | -93.02% | -6.92% |
Correlation
The correlation between TXG and BBP is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
TXG vs. BBP - Performance Comparison
In the year-to-date period, TXG achieves a -74.77% return, which is significantly lower than BBP's 9.19% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TXG vs. BBP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for 10x Genomics, Inc. (TXG) and Virtus LifeSci Biotech Products ETF (BBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TXG vs. BBP - Dividend Comparison
Neither TXG nor BBP has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
TXG 10x Genomics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
Drawdowns
TXG vs. BBP - Drawdown Comparison
The maximum TXG drawdown since its inception was -93.02%, which is greater than BBP's maximum drawdown of -44.32%. Use the drawdown chart below to compare losses from any high point for TXG and BBP. For additional features, visit the drawdowns tool.
Volatility
TXG vs. BBP - Volatility Comparison
10x Genomics, Inc. (TXG) has a higher volatility of 14.54% compared to Virtus LifeSci Biotech Products ETF (BBP) at 6.64%. This indicates that TXG's price experiences larger fluctuations and is considered to be riskier than BBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.